Thazha Prakash

Dr. Thazha Prakash

Ionis Pharamceuticals Inc.

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 July 2016 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
WWW. Brad Wan
W. Brad Wan
TPThazha Prakash
Thazha Prakash

5 October 2018 in Science Advances
Verified
Journal Article
Open access
PDF file
CÄC. Ämmälä
C. Ämmälä
WDW. J. Drury
W. J. Drury
LKL. Knerr
L. Knerr
IAI. Ahlstedt
I. Ahlstedt
PSP. Stillemark-Billton
P. Stillemark-Billton
SAShalini Andersson
Shalini Andersson
Receptor-dependent productive uptake of GLP1-conjugated antisense oligonucleotides occurs selectively in pancreatic β-cells.

22 February 2016 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
CMColton M. Miller
Colton M. Miller
ADAaron J. Donner
Aaron J. Donner
EBEmma E. Blank
Emma E. Blank
AEAndrew W. Egger
Andrew W. Egger
BKBrianna M. Kellar
Brianna M. Kellar
Edward N. HarrisEdward N. Harris
Edward N. Harris
Phosphorothioate (PS)-modified antisense oligonucleotides (ASOs) have been extensively investigated over the past three decades as pharmacological and therapeutic agents. One second generation ASO, Kynamro™, was recently approved by the FDA for the treatment of homozygous familial hypercholesterolemia and over 35 second generation PS ASOs are at various stages of clinical development. In this report, we show that the Stabilin class of scavenger receptors, which were not previously thought to bind DNA, do bind and internalize PS ASOs. With the use of primary cells from mouse and rat livers and recombinant cell lines each expressing Stabilin-1 and each isoform of Stabilin-2 (315-HARE and 190-HARE), we have determined that PS ASOs bind with high affinity and these receptors are responsible for bulk, clathrin-mediated endocytosis within the cell. Binding is primarily dependent on salt-bridge formation and correct folding of the intact protein receptor. Increased internalization rates also enhanced ASO potency for reducing expression of the non-coding RNA Malat-1, in Stabilin-expressing cell lines. A more thorough understanding of mechanisms by which ASOs are internalized in cells and their intracellular trafficking pathways will aid in the design of next generation antisense agents with improved therapeutic properties.

25 May 2019 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
TPThazha Prakash
Thazha Prakash
AMAdam E Mullick
Adam E Mullick
RLRichard G Lee
Richard G Lee
JYJinghua Yu
Jinghua Yu
SYSteve T Yeh
Steve T Yeh
TPThazha Prakash
Thazha Prakash
Enhancing the functional uptake of antisense oligonucleotide (ASO) in the muscle will be beneficial for developing ASO therapeutics targeting genes expressed in the muscle. We hypothesized that improving albumin binding will facilitate traversal of ASO from the blood compartment to the interstitium of the muscle tissues to enhance ASO functional uptake. We synthesized structurally diverse saturated and unsaturated fatty acid conjugated ASOs with a range of hydrophobicity. The binding affinity of ASO fatty acid conjugates to plasma proteins improved with fatty acid chain length and highest binding affinity was observed with ASO conjugates containing fatty acid chain length from 16 to 22 carbons. The degree of unsaturation or conformation of double bond appears to have no influence on protein binding or activity of ASO fatty acid conjugates. Activity of fatty acid ASO conjugates correlated with the affinity to albumin and the tightest albumin binder exhibited the highest activity improvement in muscle. Palmitic acid conjugation increases ASO plasma Cmax and improved delivery of ASO to interstitial space of mouse muscle. Conjugation of palmitic acid improved potency of DMPK, Cav3, CD36 and Malat-1 ASOs (3- to 7-fold) in mouse muscle. Our approach provides a foundation for developing more effective therapeutic ASOs for muscle disorders.

20 August 2021 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
BABrooke A Anderson
Brooke A Anderson
GFGraeme C Freestone
Graeme C Freestone
ALAudrey Low
Audrey Low
CDCheryl L De-Hoyos
Cheryl L De-Hoyos
WIWilliam J Drury Iii
William J Drury Iii
TPThazha Prakash
Thazha Prakash
The PS modification enhances the nuclease stability and protein binding properties of gapmer antisense oligonucleotides (ASOs) and is one of very few modifications that support RNaseH1 activity. We evaluated the effect of introducing stereorandom and chiral mesyl-phosphoramidate (MsPA) linkages in the DNA gap and flanks of gapmer PS ASOs and characterized the effect of these linkages on RNA-binding, nuclease stability, protein binding, pro-inflammatory profile, antisense activity and toxicity in cells and in mice. We show that all PS linkages in a gapmer ASO can be replaced with MsPA without compromising chemical stability and RNA binding affinity but these designs reduced activity. However, replacing up to 5 PS in the gap with MsPA was well tolerated and replacing specific PS linkages at appropriate locations was able to greatly reduce both immune stimulation and cytotoxicity. The improved nuclease stability of MsPA over PS translated to significant improvement in the duration of ASO action in mice which was comparable to that of enhanced stabilized siRNA designs. Our work highlights the combination of PS and MsPA linkages as a next generation chemical platform for identifying ASO drugs with improved potency and therapeutic index, reduced pro-inflammatory effects and extended duration of effect.

29 April 2019 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
MMMichael T Migawa
Michael T Migawa
WSWen Shen
Wen Shen
WWW Brad Wan
W Brad Wan
GVGuillermo Vasquez
Guillermo Vasquez
MOMichael E Oestergaard
Michael E Oestergaard
TPThazha Prakash
Thazha Prakash
Phosphorothioate-modified antisense oligonucleotides (PS-ASOs) interact with a host of plasma, cell-surface and intracellular proteins which govern their therapeutic properties. Given the importance of PS backbone for interaction with proteins, we systematically replaced anionic PS-linkages in toxic ASOs with charge-neutral alkylphosphonate linkages. Site-specific incorporation of alkyl phosphonates altered the RNaseH1 cleavage patterns but overall rates of cleavage and activity versus the on-target gene in cells and in mice were only minimally affected. However, replacing even one PS-linkage at position 2 or 3 from the 5′-side of the DNA-gap with alkylphosphonates reduced or eliminated toxicity of several hepatotoxic gapmer ASOs. The reduction in toxicity was accompanied by the absence of nucleolar mislocalization of paraspeckle protein P54nrb, ablation of P21 mRNA elevation and caspase activation in cells, and hepatotoxicity in mice. The generality of these observations was further demonstrated for several ASOs versus multiple gene targets. Our results add to the types of structural modifications that can be used in the gap-region to enhance ASO safety and provide insights into understanding the biochemistry of PS ASO protein interactions.